MENU
XOMA
AS OF
Feb 4 closing price
Price
$26.91
Change
-$0.06 (-0.22%)
Capitalization
333.35M
28 days until earnings call
Intraday BUY SELL Signals
+Compare
XOMA
Stock ticker: NASDAQ
AS OF
Feb 4 closing price
Price
$26.91
Change
-$0.06 (-0.22%)
Capitalization
333.35M

XOMA XOMA Royalty Corporation Forecast, Technical & Fundamental Analysis

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health... Show more

Industry: #Biotechnology
XOMA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for XOMA with price predictions
Feb 04, 2026

XOMA sees its Stochastic Oscillator recovers from oversold territory

On February 02, 2026, the Stochastic Oscillator for XOMA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 64 instances where the indicator left the oversold zone. In of the 64 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for XOMA just turned positive on February 03, 2026. Looking at past instances where XOMA's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XOMA advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XOMA as a result. In of 107 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for XOMA moved below the 200-day moving average on January 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XOMA broke above its upper Bollinger Band on January 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for XOMA entered a downward trend on January 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.089) is normal, around the industry mean (26.526). P/E Ratio (35.893) is within average values for comparable stocks, (51.406). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.895). Dividend Yield (0.020) settles around the average of (0.043) among similar stocks. P/S Ratio (35.211) is also within normal values, averaging (329.988).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. XOMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XOMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
XOMA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

XOMA is expected to report earnings to fall 115.71% to -10 cents per share on March 05

XOMA Royalty Corporation XOMA Stock Earnings Reports
Q4'25
Est.
$-0.11
Q3'25
Beat
by $0.79
Q2'25
Beat
by $0.64
Q1'25
Beat
by $0.35
Q4'24
Beat
by $0.25
The last earnings report on November 12 showed earnings per share of 69 cents, beating the estimate of -9 cents. With 203.41K shares outstanding, the current market capitalization sits at 333.35M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical preparations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2200 Powell Street
Phone
+1 510 204-7200
Employees
13
Web
https://www.xoma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SFTBY13.300.04
+0.30%
Softbank Group Corp
IGESF0.12N/A
N/A
Igas Energy PLC
MTLHY32.40N/A
N/A
Mitsubishi Chemical Group Corporation
RSDEF2.39N/A
N/A
Ramsdens Holdings PLC
ZHHJY7.81N/A
N/A
Zhejiang Shibao Co Ltd

XOMA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMA has been loosely correlated with LENZ. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMA jumps, then LENZ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMA
1D Price
Change %
XOMA100%
+1.89%
LENZ - XOMA
65%
Loosely correlated
-4.72%
VTGN - XOMA
63%
Loosely correlated
-6.19%
ARCT - XOMA
60%
Loosely correlated
-0.68%
RZLT - XOMA
60%
Loosely correlated
-2.78%
QNCX - XOMA
57%
Loosely correlated
-19.22%
More